Year: 2020
Type: article
Abstract: Antiretroviral therapy that reduces viral replication could limit the transmission of human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples.
DOI: 10.17615/2cgr-nw08
Authors: Eshleman, Susan H., Cohen, Myron S., Chariyalertsak, Suwat, Sanne, Ian, Elharrar, Vanessa, Gamble, Theresa, Gallant, Joel, McCauley, Marybeth, Hosseinipour, Mina C., de Bruyn, Guy, Kumwenda, Johnstone, Hakim, James G., Chen, Ying Q., Hoffman, Irving F., Makhema, Joseph, Mills, Lisa A., Pilotto, Jose H.S., Nielsen-Saines, Karin, Taha, Taha E., Godbole, Sheela V., Havlir, Diane, Eron, Joseph, Mehendale, Sanjay, Swindells, Susan, Wang, Lei, Ribaudo, Heather, Mayer, Kenneth H., Santos, Breno R., Grinsztejn, Beatriz, Kumarasamy, Nagalingeswaran, Piwowar-Manning, Estelle, Burns, David
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Abbott Laboratories, Bristol-Myers Squibb, Pfizer, GlaxoSmithKline, Sanofi, Gilead Sciences, University of Nebraska Medical Center, Johns Hopkins University, ViiV Healthcare, Chiang Mai University, Centers for Disease Control and Prevention, Center for AIDS Research, University of Washington, University of California, San Francisco, Johns Hopkins Bloomberg School of Public Health, Abbott Diagnostics, Sanofi Pasteur, National Institute of Allergy and Infectious Diseases
Awards: G5768112423, G793395730, G95499620, G95938990
OpenAlex ID: W4298726241